DOI: 10.1056/NEJMoa2306963 [Google Scholar] Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hanselmann A, et al
These facilities are required to maintain full compliance with current good manufacturing practices (cGMP), the same cGMP standards to which generic and brand-name medications are held. A recent article compared the safety reports from adverse events from brand-name medication vs
For successful product reformulations, manufacturers need to consider nutritional, functional, and organoleptic properties of ingredients for the best, craveable outcomes
Healthcare providers should work closely with patients to weigh the potential risks and benefits of GLP-1 therapy and tailor treatment plans to individual needs and preferences